Luxi Yang

Sigma–1 receptor activation alleviates blood–brain barrier disruption post cerebral ischemia stroke by stimulating the GDNF–GFRα1–RET pathway

P. Liu, Xiao-xiao Qi, Danyang Liu, 2021, Experimental Neurology.

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.

A. Drilon, M. Burkard, T. Owonikoko, 2020, The New England journal of medicine.

Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.

A. Drilon, Keunchil Park, Y. Ohe, 2020, The New England journal of medicine.

Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways.

D. Cui, Jian-ming Zheng, Z. Cai, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Puerarin Suppresses Invasion and Vascularization of Endometriosis Tissue Stimulated by 17β-Estradiol

Ling Xu, Z. Cai, Chaoqin Yu, 2011, PloS one.

Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer.

T. Owonikoko, D. Tan, M. Brose, 2020 .

Abstract LB001: Anti-tumor activity and tolerability of the SHP2 inhibitor RMC-4630 as a single agent in patients with RAS-addicted solid cancers

P. Jänne, J. Riess, H. Burris, 2021, Experimental and Molecular Therapeutics.